Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,256 | 20,173 | 17,948 | 5,091 | 24,571 |
| Marketable Securities | 16,279 | 302 | 83,940 | 108,095 | 226,041 |
| Receivables | 5,200 | 4,752 | 9,319 | 7,022 | 4,934 |
| Inventories | 5,448 | 11,121 | 22,892 | 29,761 | 12,387 |
| TOTAL | $45,386 | $39,489 | $140,118 | $157,298 | $272,414 |
| Non-Current Assets | |||||
| PPE Net | 14,847 | 19,219 | 23,345 | 18,029 | 10,318 |
| Intangibles | 4,345 | 9,705 | 33,974 | 118,432 | 83,002 |
| Other Non-Current Assets | 9,006 | 8,257 | 16,967 | 13,743 | 11,366 |
| TOTAL | $28,198 | $37,181 | $74,286 | $150,204 | $104,686 |
| Total Assets | $73,584 | $76,670 | $214,404 | $307,502 | $377,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,590 | 6,962 | 10,384 | 12,534 | 10,769 |
| Accrued Expenses | 5,460 | 5,641 | 8,089 | 10,552 | 8,621 |
| Other current liabilities | 967 | 1,128 | 9,317 | 10,253 | 684 |
| TOTAL | $22,942 | $37,344 | $100,028 | $35,884 | $21,840 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,738 | 412 | 14,634 | 18,601 | 14,500 |
| TOTAL | $6,218 | $3,951 | $18,219 | $22,220 | $18,142 |
| Total Liabilities | $29,160 | $41,295 | $118,247 | $58,104 | $39,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,092 | 3,007 | 913 | 511 | 484 |
| Common Shares | 1 | N/A | N/A | 3 | 29 |
| Retained earnings | -719,620 | -693,225 | -581,208 | -348,715 | -216,119 |
| Other shareholders' equity | 17 | 27 | 23 | -1,124 | -539 |
| TOTAL | $44,424 | $35,375 | $96,157 | $249,398 | $337,118 |
| Total Liabilities And Equity | $73,584 | $76,670 | $214,404 | $307,502 | $377,100 |